Intra-Cellular Therapies (ITCI) Insider Trading & Ownership → The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad) Free ITCI Stock Alerts $73.12 -0.89 (-1.20%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Intra-Cellular Therapies (NASDAQ:ITCI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.40%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$43.93 M Get ITCI Insider Trade Alerts Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ITCI Insider Buying and Selling by Quarter Ad Huge AlertsThe #1 Biotech Stock to Have on Your Radar in 2024… Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!Learn more about why Zack’s has a BULLISH nearly $19 price target on BSEM right now! Intra-Cellular Therapies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/11/2024Lawrence J. HinelineCFOSell10,121$65.96$667,581.16 3/11/2024Michael HalsteadEVPSell7,345$65.97$484,549.65 3/11/2024Sharon MatesCEOSell20,565$65.21$1,341,043.65 3/7/2024Lawrence J. HinelineCFOSell13,132$66.60$874,591.20 3/7/2024Sharon MatesCEOSell40,712$66.50$2,707,348.00 3/7/2024Suresh K DurgamEVPSell6,450$66.56$429,312.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/26/2024Joel S MarcusDirectorSell26,328$68.68$1,808,207.04 2/26/2024Lawrence J. HinelineCFOSell13,337$69.43$925,987.91 2/26/2024Michael HalsteadEVPSell7,907$69.53$549,773.71 2/26/2024Sharon MatesCEOSell22,590$69.79$1,576,556.10 1/18/2024Sharon MatesCEOSell67,917$65.19$4,427,509.23 1/16/2024Sharon MatesCEOSell75,361$67.25$5,068,027.25 1/11/2024Michael HalsteadEVPSell50,000$66.83$3,341,500.00 1/2/2024Suresh K. DurgamEVPSell62,282$70.60$4,397,109.20 12/13/2023Suresh K. DurgamEVPSell21,262$65.00$1,382,030.00 11/6/2023Mark NeumannEVPSell42,393$55.63$2,358,322.59 9/18/2023Sharon MatesCEOSell55,587$53.76$2,988,357.12 8/7/2023Mark NeumannEVPSell55,300$58.79$3,251,087.00 7/17/2023Suresh K DurgamEVPSell1,842$65.00$119,730.00 6/14/2023Lawrence J. HinelineCFOSell81,854$63.97$5,236,200.38 (Data available from 1/1/2013 forward) ITCI Insider Trading Activity - Frequently Asked Questions Who is on Intra-Cellular Therapies's Insider Roster? The list of insiders at Intra-Cellular Therapies includes Christopher D Alafi, Joel S Marcus, Lawrence J Hineline, Mark Neumann, Michael Halstead, Nostrand Robert L Van, Rory B Riggs, Sharon Mates, Suresh K Durgam. Learn more on insiders at ITCI. What percentage of Intra-Cellular Therapies stock is owned by insiders? 3.40% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings. Which Intra-Cellular Therapies insiders have been selling company stock? The following insiders have sold ITCI shares in the last 24 months: Joel S Marcus ($2,612,307.04), Lawrence J. Hineline ($15,131,817.36), Mark Neumann ($7,563,434.74), Michael Halstead ($7,062,323.36), Nostrand Robert L Van ($2,343,900.00), Sharon Mates ($25,022,530.74), and Suresh K Durgam ($1,643,805.96). How much insider selling is happening at Intra-Cellular Therapies? Insiders have sold a total of 1,154,359 Intra-Cellular Therapies shares in the last 24 months for a total of $67,159,258.40 sold. More Insider Trading Tools from MarketBeat Related Companies: Cerevel Therapeutics Insider Transactions Viking Therapeutics Insider Transactions Cytokinetics Insider Transactions Jazz Pharmaceuticals Insider Transactions Elanco Animal Health Insider Transactions Apellis Pharmaceuticals Insider Transactions Ionis Pharmaceuticals Insider Transactions Catalent Insider Transactions Blueprint Medicines Insider Transactions Madrigal Pharmaceuticals Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:ITCI) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intra-Cellular Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
